Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FDRBQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,663
Award facts
- Contract value 100% obligated
- $16,663.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,663.20 to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants on September 16, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables to support military health facilities worldwide.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, specializing in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical devices to Department of Defense healthcare sites. The company has established a robust portfolio of federal contract awards with the DLA covering diverse pharmaceutical products ranging from contraceptive devices and oncology treatments to vaccines and specialty medications. As a registered SAM.gov vendor since 2001, DMS Pharmaceutical Group has consistently competed effectively in federal procurement markets, leveraging its status as a woman-owned small business to secure multiple delivery orders for essential medical supplies supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FDRBQ?
SPE2DB25FDRBQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FDRBQ worth?
The government has obligated $16,663 on SPE2DB25FDRBQ.
Is contract SPE2DB25FDRBQ an order under another contract?
Yes. SPE2DB25FDRBQ is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDRBQ competed?
The extent of competition for SPE2DB25FDRBQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award